Register
Login

Trending Topic

14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Kate Clair Cruden Hughes, Amy Hai Yan Chan

Asthma affects nearly 300 million people worldwide.1 Despite a notable decline in age-standardized prevalence, mortality and disability-adjusted life years over the past three decades, the burden of asthma remains high in many countries including low-middle-income countries.2 Climate change is also predicted to significantly impact asthma and other respiratory-related conditions, as rising global temperatures lead to longer pollen […]

Advait Vasavada, CHEST 2022: Cannabis use disorder and thromboembolic events

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 31st 2022

Cannabis use disorder is described as the inability to stop using marijuana, despite a negative impact on health. We caught up with Dr. Advait Vasavada (M. P. Shah Medical College, Jamnagar, India) around the definition of cannabis use disorder and what we currently know about the impact of this disorder on thromboembolic events.

The abstract ‘CANNABIS USE DISORDER: FRIEND OR FOE IN PULMONARY EMBOLISM AND ASSOCIATED MORTALITY IN YOUNG ADULTS (AGED 18-44 YEARS)?’ (Poster 2051) was presented at CHEST 2022, 16-19 October, 2022.

Questions

  1. What is the definition of cannabis use disorder? (0:25)
  2. What is known about the effect of cannabis use on thromboembolic events and what are the pathophysiological processes underlying this effect? (1:16)

Disclosures: Advait Vasavada has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.

Filmed in coverage of the CHEST meeting 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup